Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 10163Neoplasms 7801Carcinoma, Non-Small-Cell Lung 5744Prostatic Neoplasms 5016Colorectal Neoplasms 4588Lung Neoplasms 3716Leukemia, Myeloid, Acute 3097Neoplasm Metastasis 3074Multiple Myeloma 3073Pancreatic Neoplasms 2837Melanoma 2646Lymphoma 2569Ovarian Neoplasms 2565Carcinoma, Hepatocellular 2473Stomach Neoplasms 2325Recurrence 2221Head and Neck Neoplasms 2095Precursor Cell Lymphoblastic Leukemia-Lymphoma 2084Lymphoma, Non-Hodgkin 2055Leukemia 2011Brain Neoplasms 1899Glioblastoma 1791Colonic Neoplasms 1790Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1714Uterine Cervical Neoplasms 1684Lymphoma, Follicular 1651Squamous Cell Carcinoma of Head and Neck 1649Lymphoma, Large B-Cell, Diffuse 1596Carcinoma, Renal Cell 1574

Interventions

tislelizumab 1pamiparib 1TNFeraseBiologic 1Injections 1Gefitinib 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Prostate Cancer × Clear all
NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
40 enrolled
Genitourinary

Locally Advanced Prostate Cancer

NCT01048151 2012-03-12

TNFerade Biologic to Treat Locally Advanced Prostate Cancer

GenVec

Phase 1 Unknown
20 enrolled
Genitourinary

Locally Advanced Prostate Cancer

NCT00319787 2011-01-25

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

AstraZeneca

Phase 2 Completed
102 enrolled
Genitourinary

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡